Derek Lowe has a post at In the Pipeline about Merck's new venture in open access. Sage, which will be headed up by Stephen Friend, is meant to "bring together genomic studies from all sorts of laboratories into a common format and database," Lowe writes. He says that challenges with IP and with varying data formats will be a major hurdle for the project -- and is none too sure the venture will "[get] off the ground at all. ...

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.